| 08.08.2023 10:00 | IPO | Technology trends webinar on AI | Reach |
| 03.08.2023 15:45 | GSEO, VANQ, BBOX | UK dividends calendar - next 7 days | Alliance |
| 02.08.2023 10:12 | IPO | IP Group interim loss narrows, confident of full year "strong returns" | Alliance |
| 02.08.2023 07:00 | IPO | IP Group half-yearly results | RNS |
| 26.07.2023 15:43 | VMUK, WRKS, SPT | UK earnings, trading statements calendar - next 7 days | Alliance |
| 13.07.2023 17:11 | IPO | Director Declaration | RNS |
| 12.07.2023 13:41 | IPO, MIRI | TR-1: form for notification of major holdings | RNS |
| 30.06.2023 10:23 | IPO | Total Voting Rights | RNS |
| 29.06.2023 18:24 | IPO | Director/PDMR Shareholding | RNS |
| 28.06.2023 11:31 | IPO | Notice of Results | RNS |
| 26.06.2023 12:41 | IPO | Director Declaration | RNS |
| 15.06.2023 15:50 | TRB, TEM, TATE | UK dividends calendar - next 7 days | Alliance |
| 15.06.2023 13:19 | IPO | Result of AGM | RNS |
| 15.06.2023 09:42 | IPO | IN BRIEF: IP Group remains well financed, cites notable investments | Alliance |
| 15.06.2023 07:00 | IPO | AGM Statement | RNS |
| 08.06.2023 15:49 | SOUC, SHC, POLN | UK shareholder meetings calendar - next 7 days | Alliance |
| 08.06.2023 08:51 | IPO | Life Sciences update event | Reach |
| 07.06.2023 11:00 | IPO, MIRI | IP Group plc - TR1 form | RNS |
| 07.06.2023 09:42 | ASC, WISE, PAG | LONDON BROKER RATINGS: Goldman cuts Croda to neutral; Davy likes Wise | Alliance |
| 31.05.2023 14:34 | IPO | Total Voting Rights | RNS |
| 26.05.2023 09:32 | IPO, VLX, SYS | IN BRIEF: SysGroup names former Volex head as exec chair; CEO to leave | Alliance |
| 18.05.2023 15:04 | WTB, VCT, TIFS | UK dividends calendar - next 7 days | Alliance |
| 12.05.2023 13:26 | IPO | Director Declaration | RNS |
| 10.05.2023 12:11 | IPO | Director/PDMR Shareholding | RNS |
| 03.05.2023 10:56 | IPO | Director Declaration | RNS |
| 28.04.2023 15:21 | IPO | Total Voting Rights | RNS |
| 20.04.2023 17:00 | IPO | Notice of AGM, Annual Report | RNS |
| 18.04.2023 15:23 | IPO | RSP & DBSP awards; Director/PDMR shareholding | RNS |
| 31.03.2023 10:01 | CWR, KWS, IPO | LONDON BROKER RATINGS: UBS likes Beazley; Berenberg cuts Wood Group | Alliance |
| 15.03.2023 09:31 | IPO | Investor presentation | Reach |
| 13.03.2023 12:18 | VRCI, SCLP, ROQ | SUMMARY: London listings with exposure to Silicon Valley Bank | Alliance |
| 13.03.2023 09:00 | IPO | Director/PDMR Shareholding | RNS |
| 13.03.2023 07:00 | IPO | No direct deposits or credit facilities with SVB | RNS |
| 08.03.2023 11:25 | IPO | IP Group turns to loss in 2022 due to fair value swing; raises payout | Alliance |
| 08.03.2023 07:00 | IPO | IP Group plc - Annual Results | RNS |
| 02.03.2023 15:25 | IPO, ITX | TR-1 | RNS |
| 01.03.2023 15:57 | TLW, TTG, SPT | UK earnings, trading statements calendar - next 7 days | Alliance |
| 21.02.2023 08:51 | IPO | IP Group sees AMSL Aero soar on maiden flight for electric aircraft | Alliance |
| 21.02.2023 07:00 | IPO | AMSL Aero's all-electric aircraft maiden flight | Reach |
| 10.02.2023 09:55 | IPO | Notice of Results | RNS |
| 31.01.2023 10:00 | IPO | Total Voting Rights | RNS |
| 30.01.2023 10:32 | IPO | TOP NEWS: Hambro Perks will not merge with IP Group drug firm Istesso | Alliance |
| 30.01.2023 07:00 | IPO | Statement re press speculation | RNS |
| 24.01.2023 13:18 | MIRI, IPO | Form 8.3 - Mirriad Advertising plc | RNS |
| 18.01.2023 11:10 | IPO, GSK | IN BRIEF: IP Group appoints GSK's Anita Kidgell as non-executive | Alliance |
| 18.01.2023 07:00 | IPO | Directorate Change | RNS |
| 11.01.2023 11:45 | OCDO, IPO | IP Group portfolio company Oxbotica raises GBP115 million | Alliance |
| 11.01.2023 07:00 | IPO | Portfolio company Oxbotica raises $140m Series C | RNS |
| 03.01.2023 11:48 | IPO | Total Voting Rights | RNS |
| 12.12.2022 16:58 | IPO | AGM post-meeting shareholder engagement update | RNS |
| 07.12.2022 16:39 | IPO | Holding(s) in Company | RNS |
| 05.12.2022 09:18 | IPO | IP Group portfolio company gains FDA fast track status for lead drug | Alliance |
| 05.12.2022 07:00 | IPO | Istesso announces FDA Fast Track for MBS2320 | Reach |
| 02.12.2022 11:38 | IPO | Portfolio company funding leads to £36m gain | RNS |
| 30.11.2022 10:41 | IPO | Total Voting Rights | RNS |
| 21.11.2022 14:13 | IPO | Life sciences presentation postponed | Reach |
| 02.11.2022 15:51 | IPO | Investor presentation on life sciences | Reach |
| 01.11.2022 08:59 | IPO | Notification of major holdings | RNS |
| 31.10.2022 16:35 | IPO | Director/PDMR Shareholding | RNS |
| 27.10.2022 16:55 | IPO | PDMR Dealing – SAYE Exercise | RNS |
| 24.10.2022 18:02 | IPO, XSG | Holding(s) in Company | RNS |
| 14.10.2022 09:42 | IPO | Holding(s) in Company | RNS |
| 30.09.2022 10:39 | IPO | Total Voting Rights | RNS |
| 21.09.2022 17:29 | IPO | Holding(s) in Company | RNS |
| 20.09.2022 18:10 | IPO | Director/PDMR Shareholding | RNS |
| 15.09.2022 16:41 | IPO | Investor presentation | Reach |
| 14.09.2022 16:33 | IPO | Further re Scrip Dividend | RNS |
| 13.09.2022 18:00 | IPO | Further re Interim Scrip Dividend | RNS |
| 13.09.2022 07:00 | IPO | IP Group Trust (IPO): Initiation — International investor in impactful innovation | EQS |
| 12.09.2022 15:55 | QLT, PSON, IPO | UK dividends calendar - next 7 days | Alliance |
| 07.09.2022 16:33 | IPO | Director/PDMR Shareholding, SAYE scheme | RNS |
| 31.08.2022 10:27 | IPO | IP Group portfolio company begins phase two trial of arthritis drug | Alliance |
| 31.08.2022 08:51 | IPO | Istesso starts Phase 2b trial of MBS2320 | Reach |
| 30.08.2022 12:59 | IPO | Cash acquisition of portfolio company Diurnal | Reach |
| 18.08.2022 09:25 | IPO | Scrip Dividend Reference Price | RNS |
